Goldman Sachs’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $822K | Sell |
|
|||||
|
2025
Q2 | $692K | Buy |
|
|||||
|
2025
Q1 | $642K | Buy |
|
|||||
|
2024
Q4 | $5.88M | Buy |
|
|||||
|
2024
Q3 | $3.89M | Buy |
|
|||||
|
2024
Q2 | $2.29M | Sell |
|
|||||
|
2024
Q1 | $7.49M | Buy |
|
|||||
|
2023
Q4 | $7.01M | Buy |
|
|||||
|
2023
Q3 | $2.86M | Sell |
|
|||||
|
2023
Q2 | $4.1M | Sell |
|
|||||
|
2023
Q1 | $7.01M | Buy |
|
|||||
|
2022
Q4 | $2.85M | Buy |
|
|||||
|
2022
Q3 | $2.14M | Sell |
|
|||||
|
2022
Q2 | $3.45M | Buy |
|
|||||
|
2022
Q1 | $1M | Buy |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | $558K | Buy |
|
|||||
|
2021
Q2 | $739K | Buy |
|
|||||
|
2021
Q1 | $579K | Sell |
|
|||||
|
2020
Q4 | $410K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.46M | Buy |
|